Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nerve block volume study aims to ease hip surgery pain

NCT ID NCT06166602

Symptom relief Sponsor: Istanbul Medeniyet University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how much local anesthetic to use in a nerve block (called PENG block) to control pain after hip replacement surgery. 50 adults having hip surgery received different volumes of the block. The goal was to find the best dose to reduce pain, lower the need for painkillers, and improve patient comfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Jul 2023

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients with informed consent 2. Patients planned for hip surgery 3. Those between the ages of 18-80 4. ASA (American Society of Anesthesiologists) I-III patients Exclusion Criteria: 1. Patients who do not give consent 2. Patients with coagulopathy 3. Patients with a history of local anesthetic drug allergy and toxicity 4. Patients with advanced organ failure 5. Patients with mental retardation 6. Patients with infection at the injection site 7. Pediatric patients and patients over 80 years of age 8. Pregnant patients will not be included in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip surgery are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip surgery Postoperative pain Regional anesthesia

Contacts and locations

Locations

  • Istanbul Medeniyet University

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.